The development and hosting of this resource hub has been commissioned by Roche Diagnostics Limited (Roche). This resource hub contains links to Guidelines and Guidelines in Practice independent educational content, clinical resources, and additional items from Roche, some of which may be promotional in nature.
The following resources, some of which may be promotional in nature, were provided by Roche Diagnostics Limited.
Patients on long-term vitamin K antagonist therapy require regular monitoring and healthcare professionals should regularly review the ability of patients and carers to use their self-monitoring devices effectively.
NICE recommends self-monitoring of coagulation status in adults and children on long-term vitamin K antagonist therapy who have atrial fibrillation or heart valve disease if people prefer this form of testing and if the person or their carer is both physically and cognitively able to self-monitoring effectively.
The pack covers several key areas that will provide healthcare professionals and their organisation with information on building a business case and operational plan to implement a self-monitoring service.
Online eLearning modules
Helicon Health Limited has developed eLearning courses designed to provide patients with the knowledge, skills, and confidence to monitor oral anticoagulation therapy. Introductory modules are available free of charge and offer educational content on:
- the benefits of self-monitoring
- testing international normalised ratio using a coagulometer
- how anticoagulants affect blood clotting.
Visit www.strokeprevent.live to learn more.
CoaguChek Handling videos
The following handling videos can be used when training your patients on how to use their self-testing meter. Copies of these training videos are also provided for patients on the CoaguChek website training page and as a DVD provided with a meter purchase.
CoaguChek INRange handling video
CoaguChek XS handling video
CoaguChek XS Pro Handling videos
CoaguChek XS Plus Handling videos
The case studies outline local initiatives that have transitioned from laboratory testing to a near patient testing service for warfarin management. They cover aspects such as patient experience and clinical practice, and outlined the resulting outcomes, including improved control of international normalised ratio and patient empowerment.
- Optimising warfarin monitoring – three novel approaches: Great Western Hospital, Whitby Group Practice, and NHS Bury
- Warfarin management in primary care: Largs Medical Group
- Improving INR control and patient satisfaction in primary care: Littlewick Medical Centre
- Home INR testing improves management of paediatric cardiology patients on warfarin therapy: University Hospital of Wales